Three Monash University clinicians are making news this week with the initial results from the bidirectional cannula trial: http://www.9news.com.au/health/2017/08/15/00/06/melbourne-invention-saves-lives-and-limbs.
The device was developed by cardiothoracic surgeon Randall Moshinsky, Cardiac anaesthetist Dr Elli Tutungi and Head of Perfusion Jim McMillan developed the device.
Research Path were pleased to be engaged by Alfred Health on behalf of sponsor MTMM Pty Ltd to complete data collection design, and use of the Research Base Clinical Trial Management System (CTMS) for data entry and validation.
Funding for this trial was provided though the Victorian Government Health Market Validation Program. The device is expected to be on the market in 2018.
Find out more about this life saving device:
Planning a Phase I Trial? Get in touch with us to discuss options for data collection design, and online data collection and management. Our Clinical Trial Management System also supports drug allocation and tracking for drug trials - firstname.lastname@example.org.